through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
Asthma is one of the most common chronic respiratory conditions worldwide, yet diagnosing it has never been entirely straightforward. Unlike diabetes or hypertension, asthma has no single “gold standard” blood test or scan tha...
For decades, spirometry has been the cornerstone of lung function testing. A patient takes a deep breath and blasts it out as hard and fast as possible, and the numbers that emerge—FEV1, FVC, and their ratio—tell clinicians wh...
By e-linkcare | Clinical Respiratory Insights Fractional exhaled nitric oxide (FeNO) testing is now widely recognized as a non-invasive biomarker of type 2 airway inflammation. It helps clinicians assess airway inflammation, predict corti...
Please complete the form to contact our team